STOCK TITAN

Accolade Welcomes Kindbody to Trusted Partner Ecosystem

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Accolade, Inc. partners with Kindbody to offer comprehensive fertility and family-building services to its customers and members. Kindbody's unique model provides affordable, integrated, and best-in-class care for infertility and family-forming journeys, addressing the fragmented and siloed nature of fertility services in the United States.
Positive
  • Partnership with Kindbody expands Accolade's offerings for women's health, fertility, and family-building capabilities.
  • Kindbody provides affordable fertility care with a unique physician-led clinical model and a combination of owned and operated clinics and partner clinics nationwide.
  • Services offered by Kindbody include female and male fertility assessments, genetic testing, IVF, surrogacy, adoption services, integrative holistic health specialists, pregnancy support, and menopause-related health support.
  • The partnership aims to bridge the Physician Gap and provide better support for fertility and family-building services to shared customers.
Negative
  • None.

Insights

The partnership between Accolade and Kindbody signifies a strategic move in the healthcare industry, particularly within the women's health and fertility sector. By incorporating Kindbody's network and services into its Trusted Partner Ecosystem, Accolade is addressing a critical gap in employer-provided health benefits, which often exclude comprehensive fertility and family-building support. This collaboration has the potential to reshape employer-based insurance plans, making them more inclusive and appealing to a workforce that increasingly values such benefits.

From a business perspective, the inclusion of fertility services could lead to a competitive advantage for Accolade in attracting and retaining customers. The cost savings performance guarantee mentioned could also alleviate financial concerns for employers and employees alike, possibly leading to increased utilization of Accolade's services. However, the financial impact will depend on the adoption rate among Accolade's customers and the effectiveness of the integrated care model in reducing costs.

With approximately one in six couples in the U.S. affected by infertility, the demand for accessible and affordable fertility treatments is substantial. Kindbody's approach to providing a seamless, integrated experience with a focus on both virtual and in-person care is reflective of broader trends in healthcare towards digitization and patient-centric services. This partnership could set a precedent for how healthcare providers offer comprehensive care, potentially influencing market expectations and standards.

Moreover, the unique positioning of Kindbody as both a service provider and a direct care provider could disrupt the traditional fertility services market, which is a point of interest for investors monitoring innovation and growth potential within the healthcare sector.

Investors will be closely monitoring the financial implications of this partnership for Accolade. The company's stock performance may be influenced by the market's perception of the partnership's ability to generate additional revenue streams and improve profit margins through the cost savings performance guarantee. It's essential to analyze the long-term financial outcomes, such as the potential for increased market share and customer loyalty, as well as the short-term costs associated with integrating Kindbody's services.

Additionally, the partnership's success will hinge on its execution and the response from Accolade's customer base. Investors should look for quantitative metrics in future financial reports, such as customer acquisition and retention rates, to gauge the partnership's impact on Accolade's bottom line.

Kindbody partnership builds on Accolade's commitment to offer best-in-class women's health, fertility and family-forming capabilities for customers and members

SEATTLE, Jan. 23, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced that Kindbody, a technology-driven fertility clinic network and family-building benefits provider for employers, will join the company's Trusted Partner Ecosystem to offer Accolade customers comprehensive, clinically guided support and care throughout a member's fertility and family-building journey, all backed by a new cost savings performance guarantee.

Approximately one in six couples are affected by infertility in the United States. Yet fertility and family-building services are fragmented and siloed, and employees often struggle to find support in the workplace when facing infertility and subsequent treatment, as many employer-based insurance plans do not cover the high cost of fertility treatment.

Kindbody addresses these issues by providing affordable fertility care and delivering a seamless, integrated experience with best-in-class outcomes. Kindbody's physician-led clinical model supports the end-to-end fertility and family-building journey, bringing care to members everywhere by offering virtual and onsite care, mobile clinics, and at-home testing. Kindbody delivers this model through a combination of owned and operated signature clinics and hundreds of partner clinics nationwide. Kindbody's model is unique in that it is the only family-building benefits provider for employers that is also in the direct provision of care.

Kindbody covers the full continuum of reproductive health through female and male fertility assessments, education, and services, including genetic testing and IVF, as well as donor, surrogacy, and adoption services.  Members also have access to integrative holistic health specialists, from therapists to nutritional health practitioners, through a convenient virtual telehealth platform. Other services Kindbody offers include pregnancy support, baby preparation, and maternity support, virtual doula care, and return to work coaching. Additionally, Kindbody supports all facets of health related to perimenopause and menopause with a network of integrated providers and curated digital tools and resources.

"Fertility care is increasingly expensive and challenging to access," said Accolade Chief Medical Officer Dr. Connie Hwang. "Partnering with Kindbody offers Accolade an opportunity to build on our commitment to bridge the Physician Gap by offering best-in-class women's health, fertility, and family-building solutions to our customers, through both in-house programming and strategic collaboration with our Trusted Partners. Kindbody shares our commitment to provide comprehensive, affordable, and integrated clinical solutions and together we will provide our shared customers with better support for fertility and family-building services."

"Kindbody is on a mission to reinvent the delivery of reproductive health and fertility care by providing an accessible network of clinics, tech-enabled services, and integrated health solutions to members," said Kindbody CEO Annbeth Eschbach. "We are excited about partnering with Accolade to help increase awareness of Kindbody's solution across members we jointly serve and ultimately improve access to an essential healthcare benefit by reaching more employers."

Joint customers of Accolade and Kindbody will benefit from integrations designed to promote awareness of Kindbody's services, at no incremental cost to customers. For example, women's health concerns are one of the top reasons members seek out Accolade's expert medical opinion service, which reinforces the value of Accolade's expert medical opinion integrations with Kindbody and other Trusted Partners.

Additionally, Kindbody is going a step further for Accolade customers by offering a performance guarantee in which the average cost per member who utilizes Kindbody is capped at a substantial discount to the industry average. Through this guarantee and Kindbody's proven ability to generate savings while delivering best-in-class outcomes, employers can be confident their employees are receiving high quality services at affordable rates.

Launched in 2019, Accolade's Trusted Partner Ecosystem is the first in the industry to bring together multiple benefits solutions across valued categories, making them available to employers through a single front door. Accolade's ecosystem consists of 16 partners across 11 categories, including:

  • Behavioral health (Headspace, Lyra, Equip)
  • Benefits selection (Jellyvision)
  • Centers of excellence (Carrum Health, Employer Direct Healthcare)
  • Diabetes (Virta)
  • Fertility (Carrot Fertility, Kindbody)
  • Financial health (Brightside)
  • Gastrointestinal (Vivante Health)
  • Health equity (FOLX)
  • Musculoskeletal (Hinge Health, Sword Health)
  • Pharmacy (Rx Savings Solutions)
  • Wellness (WellRight)

Benefits teams can confidently select from thoroughly vetted solutions and enjoy streamlined contracting and implementation. Through our qualified referrals, we drive, measurably, more engagement with partner solutions, leading to better health outcomes and better value. Learn more about our Trusted Partners here.

About Accolade 
Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade's employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedInX, Instagram and Facebook

About Kindbody
Kindbody is the leading national fertility clinic network and global family-building benefits provider for employers offering the full spectrum of reproductive care from preconception to postpartum through menopause. Kindbody is the trusted fertility benefits provider for 132 leading employers, covering almost 2.7 million lives. Many thousands more receive their fertility care directly from Kindbody throughout the country at signature clinics, mobile clinics, and partner clinics. As the fertility benefits provider, technology platform, and direct provider of care, Kindbody delivers a seamless, integrated experience with superior health outcomes at lower cost, making fertility care more affordable and accessible for all. Kindbody has raised $315 million in debt and equity funding from leading investors including Perceptive Advisors, JP Morgan Chase's Morgan Health, GV (formerly Google Ventures), RRE Ventures, Claritas Health Ventures, Rock Springs Capital, Distributed Ventures, Whatif Ventures and TQ Ventures. Visit www.kindbody.com. and follow us on Instagram, X, and Linkedin.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accolade-welcomes-kindbody-to-trusted-partner-ecosystem-302042017.html

SOURCE Accolade, Inc.

FAQ

What is the significance of the partnership between Accolade and Kindbody?

The partnership aims to offer comprehensive, clinically guided support and care for fertility and family-building journeys to Accolade customers and members.

What services does Kindbody provide through the partnership?

Kindbody offers female and male fertility assessments, genetic testing, IVF, surrogacy, adoption services, integrative holistic health specialists, pregnancy support, and menopause-related health support.

How does Kindbody deliver its fertility care services?

Kindbody delivers its services through a unique physician-led clinical model and a combination of owned and operated clinics and partner clinics nationwide.

What is the goal of the partnership between Accolade and Kindbody?

The partnership aims to bridge the Physician Gap and provide better support for fertility and family-building services to shared customers.

Accolade, Inc.

NASDAQ:ACCD

ACCD Rankings

ACCD Latest News

ACCD Stock Data

271.41M
77.99M
3.16%
83.54%
4.52%
Health Information Services
Services-business Services, Nec
Link
United States of America
PLYMOUTH MEETING